Antibody therapy training phagocytes to destroy tumors now tested on patients

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumours in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.

Leave a Reply

Your email address will not be published.